An Ion Channel Chip for Diagnosis and Prognosis of Autoimmune Neurological Disorders

ISSN: 2212-3954 (Online)
ISSN: 1574-8898 (Print)

Volume 10, 2 Issues, 2015

Download PDF Flyer

Recent Patents on CNS Drug Discovery

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Vincenzo Di Marzo
Istituto di Chimica Biomolecolare (I.C.B.)
Consiglio Nazionale delle Ricerche (C.N.R.)
Via Campi Flegrei 34
Pozzuoli, Napoli 80078

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

An Ion Channel Chip for Diagnosis and Prognosis of Autoimmune Neurological Disorders

Recent Patents on CNS Drug Discovery, 8(3): 171-179.

Author(s): Franck C. Chatelain, Michel Mazzuca, Marie-Madeleine Larroque, Veronique Rogemond, Jerome Honnorat and Florian Lesage.

Affiliation: PMC CNRS, 660 Route des Lucioles, 06560 Valbonne Sophia Antipolis, France.


Autoantibodies directed against ion channels and ionotropic receptors are associated with neuromuscular and neurological disorders. Their detection has proven to be useful for diagnosis, prognosis and treatment of these autoimmune syndromes. We have designed an ion channel chip for the systematic and rapid screening of antibodies directed against tens of different ion channels. The chip has been validated by confirming the presence of autoantibodies in patients with anti-NMDA receptor encephalitis. Such a chip will be useful for the diagnosis of already documented disorders, but also to identify new targets of autoimmunity and classification of the corresponding diseases. The article presents some promising patents on the Ion Channel Chip.


Autoimmunity, excitability, ion channels, ionotropic receptors, protein array.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 8
Issue Number: 3
First Page: 171
Last Page: 179
Page Count: 9
DOI: 10.2174/15748898113086660004

Related Journals

Webmaster Contact: Copyright © 2015 Bentham Science